论文部分内容阅读
本文对50例脑梗塞患者采用颈动脉加压滴注复方清栓酶治疗效果进行观察,效果较满意,现分析如下:1 一般资料本组50例均为住院病人,且均于起病后48小时内入院接受该法治疗.诊断标准均按1987年第二届全国神经精神科学术会议制定的标准.临床排除脑出血及短暂性脑缺血发作.按病情分轻、中、重.神志清楚肌力Ⅳ级以上为轻度;神志清楚,肌力Ⅱ～Ⅲ级为中度;神志不清或肌力0～Ⅰ级为重度.随机选择的50例脑梗塞患者,男性28例,平均年龄61.6岁(41～79岁):女性22例,平均年龄59.4岁(43～81岁);病情轻度10例,中度21例,重度19例.左侧梗塞23例,右侧梗塞27例.其中23例有吸烟史,14例有高血压史.6例有糖尿病史,11例有 TIA 发作
In this paper, 50 cases of cerebral infarction patients with carotid artery pressure drop compound Qingshu enzyme treatment was observed, the effect is more satisfactory, are analyzed as follows: 1 General Information The group of 50 patients were hospitalized patients, and were 48 Admitted to the hospital within the hour to accept the treatment of the diagnostic criteria are based on the second session of the National Neurological and Psychiatric Academic Conference in 1987 to develop standards for clinical treatment of intracerebral hemorrhage and transient ischemic attack according to the disease sub-light, medium and heavy. Muscular strength above the level of Ⅳ mild; conscious, muscular strength Ⅱ ~ Ⅲ grade moderate; delirious or muscular 0 to Ⅰ grade was severe.Selected randomly selected 50 patients with cerebral infarction, 28 males, mean age 61.6 years old (41-79 years old): 22 females, mean age 59.4 years old (43-81 years old); mild condition in 10 cases, moderate in 21 cases, severe in 19 cases, left infarction in 23 cases and right side infarction in 27 cases 23 of them had a history of smoking, 14 had a history of hypertension, 6 had a history of diabetes, and 11 had a TIA episode